• OPEN AN ACCOUNT
Indian Indices
Sensex
72,973.68 444.61
( 0.61%)
Global Indices
Nasdaq
51,369.65 -132.86
(-0.26%)
Dow Jones
7,690.99 -13.70
(-0.18%)
Hang Seng
66,863.07 1,381.80
(2.11%)
Nikkei 225
10,628.22 -56.66
(-0.53%)
Forex
USD-INR
95.96 0.17
(0.18%)
EUR-INR
109.15 0.06
(0.06%)
GBP-INR
127.16 0.33
(0.26%)
JPY-INR
0.61 0.00
(0.14%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
140.17
446276.3
EPS(TTM)
Face Value()
Div & Yield %
13.27
1
0.86
 

Frontier Capital reports standalone net loss of Rs 0.09 crore in the March 2026 quarter
May 27,2026
Net loss of Frontier Capital reported to Rs 0.09 crore in the quarter ended March 2026 as against net profit of Rs 0.10 crore during the previous quarter ended March 2025. Sales remain constant at Rs 0.09 crore in the quarter ended March 2026 and also during the previous quarter ended March 2025.

For the full year,net profit declined 83.33% to Rs 0.05 crore in the year ended March 2026 as against Rs 0.30 crore during the previous year ended March 2025. Sales rose 2.94% to Rs 0.35 crore in the year ended March 2026 as against Rs 0.34 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.090.09 0 0.350.34 3
OPM %00 -42.8647.06 -
PBDT00.10 -100 0.140.30 -53
PBT00.10 -100 0.140.30 -53
NP-0.090.10 PL 0.050.30 -83